Ethanol Reduces Neuronal Excitability of Lateral Orbitofrontal Cortex Neurons Via a Glycine Receptor Dependent Mechanism

Trauma-induced damage to the orbitofrontal cortex (OFC) often results in behavioral inflexibility and impaired judgment. Human alcoholics exhibit similar cognitive deficits suggesting that OFC neurons are susceptible to alcohol-induced dysfunction. A previous study from this laboratory examined OFC...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychopharmacology (New York, N.Y.) Vol. 38; no. 7; pp. 1176 - 1188
Main Authors Badanich, Kimberly A, Mulholland, Patrick J, Beckley, Jacob T, Trantham-Davidson, Heather, Woodward, John J
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 01.06.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Trauma-induced damage to the orbitofrontal cortex (OFC) often results in behavioral inflexibility and impaired judgment. Human alcoholics exhibit similar cognitive deficits suggesting that OFC neurons are susceptible to alcohol-induced dysfunction. A previous study from this laboratory examined OFC mediated cognitive behaviors in mice and showed that behavioral flexibility during a reversal learning discrimination task was reduced in alcohol-dependent mice. Despite these intriguing findings, the actions of alcohol on OFC neuron function are unknown. To address this issue, slices containing the lateral OFC (lOFC) were prepared from adult C57BL/6J mice and whole-cell patch clamp electrophysiology was used to characterize the effects of ethanol (EtOH) on neuronal function. EtOH (66 mM) had no effect on AMPA-mediated EPSCs but decreased those mediated by NMDA receptors. EtOH (11-66 mM) also decreased current-evoked spike firing and this was accompanied by a decrease in input resistance and a modest hyperpolarization. EtOH inhibition of spike firing was prevented by the GABAA antagonist picrotoxin, but EtOH had no effect on evoked or spontaneous GABA IPSCs. EtOH increased the holding current of voltage-clamped neurons and this action was blocked by picrotoxin but not the more selective GABAA antagonist biccuculine. The glycine receptor antagonist strychnine also prevented EtOH's effect on holding current and spike firing, and western blotting revealed the presence of glycine receptors in lOFC. Overall, these results suggest that acutely, EtOH may reduce lOFC function via a glycine receptor dependent process and this may trigger neuroadaptive mechanisms that contribute to the impairment of OFC-dependent behaviors in alcohol-dependent subjects.
AbstractList Trauma-induced damage to the orbitofrontal cortex (OFC) often results in behavioral inflexibility and impaired judgment. Human alcoholics exhibit similar cognitive deficits suggesting that OFC neurons are susceptible to alcohol-induced dysfunction. A previous study from this laboratory examined OFC mediated cognitive behaviors in mice and showed that behavioral flexibility during a reversal learning discrimination task was reduced in alcohol-dependent mice. Despite these intriguing findings, the actions of alcohol on OFC neuron function are unknown. To address this issue, slices containing the lateral OFC (lOFC) were prepared from adult C57BL/6J mice and whole-cell patch clamp electrophysiology was used to characterize the effects of ethanol (EtOH) on neuronal function. EtOH (66mM) had no effect on AMPA-mediated EPSCs but decreased those mediated by NMDA receptors. EtOH (11-66mM) also decreased current-evoked spike firing and this was accompanied by a decrease in input resistance and a modest hyperpolarization. EtOH inhibition of spike firing was prevented by the GABAA antagonist picrotoxin, but EtOH had no effect on evoked or spontaneous GABA IPSCs. EtOH increased the holding current of voltage-clamped neurons and this action was blocked by picrotoxin but not the more selective GABAA antagonist biccuculine. The glycine receptor antagonist strychnine also prevented EtOH's effect on holding current and spike firing, and western blotting revealed the presence of glycine receptors in lOFC. Overall, these results suggest that acutely, EtOH may reduce lOFC function via a glycine receptor dependent process and this may trigger neuroadaptive mechanisms that contribute to the impairment of OFC-dependent behaviors in alcohol-dependent subjects.
Trauma-induced damage to the orbitofrontal cortex (OFC) often results in behavioral inflexibility and impaired judgment. Human alcoholics exhibit similar cognitive deficits suggesting that OFC neurons are susceptible to alcohol-induced dysfunction. A previous study from this laboratory examined OFC mediated cognitive behaviors in mice and showed that behavioral flexibility during a reversal learning discrimination task was reduced in alcohol-dependent mice. Despite these intriguing findings, the actions of alcohol on OFC neuron function are unknown. To address this issue, slices containing the lateral OFC (lOFC) were prepared from adult C57BL/6J mice and whole-cell patch clamp electrophysiology was used to characterize the effects of ethanol (EtOH) on neuronal function. EtOH (66 mM) had no effect on AMPA-mediated EPSCs but decreased those mediated by NMDA receptors. EtOH (11-66 mM) also decreased current-evoked spike firing and this was accompanied by a decrease in input resistance and a modest hyperpolarization. EtOH inhibition of spike firing was prevented by the GABA sub(A) antagonist picrotoxin, but EtOH had no effect on evoked or spontaneous GABA IPSCs. EtOH increased the holding current of voltage-clamped neurons and this action was blocked by picrotoxin but not the more selective GABA sub(A) antagonist biccuculine. The glycine receptor antagonist strychnine also prevented EtOH's effect on holding current and spike firing, and western blotting revealed the presence of glycine receptors in lOFC. Overall, these results suggest that acutely, EtOH may reduce lOFC function via a glycine receptor dependent process and this may trigger neuroadaptive mechanisms that contribute to the impairment of OFC-dependent behaviors in alcohol-dependent subjects.
Trauma-induced damage to the orbitofrontal cortex (OFC) often results in behavioral inflexibility and impaired judgment. Human alcoholics exhibit similar cognitive deficits suggesting that OFC neurons are susceptible to alcohol-induced dysfunction. A previous study from this laboratory examined OFC mediated cognitive behaviors in mice and showed that behavioral flexibility during a reversal learning discrimination task was reduced in alcohol-dependent mice. Despite these intriguing findings, the actions of alcohol on OFC neuron function are unknown. To address this issue, slices containing the lateral OFC (lOFC) were prepared from adult C57BL/6J mice and whole-cell patch clamp electrophysiology was used to characterize the effects of ethanol (EtOH) on neuronal function. EtOH (66 mM) had no effect on AMPA-mediated EPSCs but decreased those mediated by NMDA receptors. EtOH (11–66 mM) also decreased current-evoked spike firing and this was accompanied by a decrease in input resistance and a modest hyperpolarization. EtOH inhibition of spike firing was prevented by the GABA A antagonist picrotoxin, but EtOH had no effect on evoked or spontaneous GABA IPSCs. EtOH increased the holding current of voltage-clamped neurons and this action was blocked by picrotoxin but not the more selective GABA A antagonist biccuculine. The glycine receptor antagonist strychnine also prevented EtOH's effect on holding current and spike firing, and western blotting revealed the presence of glycine receptors in lOFC. Overall, these results suggest that acutely, EtOH may reduce lOFC function via a glycine receptor dependent process and this may trigger neuroadaptive mechanisms that contribute to the impairment of OFC-dependent behaviors in alcohol-dependent subjects.
Trauma-induced damage to the orbitofrontal cortex (OFC) often results in behavioral inflexibility and impaired judgment. Human alcoholics exhibit similar cognitive deficits suggesting that OFC neurons are susceptible to alcohol-induced dysfunction. A previous study from this laboratory examined OFC mediated cognitive behaviors in mice and showed that behavioral flexibility during a reversal learning discrimination task was reduced in alcohol-dependent mice. Despite these intriguing findings, the actions of alcohol on OFC neuron function are unknown. To address this issue, slices containing the lateral OFC (lOFC) were prepared from adult C57BL/6J mice and whole-cell patch clamp electrophysiology was used to characterize the effects of ethanol (EtOH) on neuronal function. EtOH (66 mM) had no effect on AMPA-mediated EPSCs but decreased those mediated by NMDA receptors. EtOH (11-66 mM) also decreased current-evoked spike firing and this was accompanied by a decrease in input resistance and a modest hyperpolarization. EtOH inhibition of spike firing was prevented by the GABAA antagonist picrotoxin, but EtOH had no effect on evoked or spontaneous GABA IPSCs. EtOH increased the holding current of voltage-clamped neurons and this action was blocked by picrotoxin but not the more selective GABAA antagonist biccuculine. The glycine receptor antagonist strychnine also prevented EtOH's effect on holding current and spike firing, and western blotting revealed the presence of glycine receptors in lOFC. Overall, these results suggest that acutely, EtOH may reduce lOFC function via a glycine receptor dependent process and this may trigger neuroadaptive mechanisms that contribute to the impairment of OFC-dependent behaviors in alcohol-dependent subjects.
Trauma-induced damage to the orbitofrontal cortex (OFC) often results in behavioral inflexibility and impaired judgment. Human alcoholics exhibit similar cognitive deficits suggesting that OFC neurons are susceptible to alcohol-induced dysfunction. A previous study from this laboratory examined OFC mediated cognitive behaviors in mice and showed that behavioral flexibility during a reversal learning discrimination task was reduced in alcohol-dependent mice. Despite these intriguing findings, the actions of alcohol on OFC neuron function are unknown. To address this issue, slices containing the lateral OFC (lOFC) were prepared from adult C57BL/6J mice and whole-cell patch clamp electrophysiology was used to characterize the effects of ethanol (EtOH) on neuronal function. EtOH (66 mM) had no effect on AMPA-mediated EPSCs but decreased those mediated by NMDA receptors. EtOH (11-66 mM) also decreased current-evoked spike firing and this was accompanied by a decrease in input resistance and a modest hyperpolarization. EtOH inhibition of spike firing was prevented by the GABAA antagonist picrotoxin, but EtOH had no effect on evoked or spontaneous GABA IPSCs. EtOH increased the holding current of voltage-clamped neurons and this action was blocked by picrotoxin but not the more selective GABAA antagonist biccuculine. The glycine receptor antagonist strychnine also prevented EtOH's effect on holding current and spike firing, and western blotting revealed the presence of glycine receptors in lOFC. Overall, these results suggest that acutely, EtOH may reduce lOFC function via a glycine receptor dependent process and this may trigger neuroadaptive mechanisms that contribute to the impairment of OFC-dependent behaviors in alcohol-dependent subjects.Trauma-induced damage to the orbitofrontal cortex (OFC) often results in behavioral inflexibility and impaired judgment. Human alcoholics exhibit similar cognitive deficits suggesting that OFC neurons are susceptible to alcohol-induced dysfunction. A previous study from this laboratory examined OFC mediated cognitive behaviors in mice and showed that behavioral flexibility during a reversal learning discrimination task was reduced in alcohol-dependent mice. Despite these intriguing findings, the actions of alcohol on OFC neuron function are unknown. To address this issue, slices containing the lateral OFC (lOFC) were prepared from adult C57BL/6J mice and whole-cell patch clamp electrophysiology was used to characterize the effects of ethanol (EtOH) on neuronal function. EtOH (66 mM) had no effect on AMPA-mediated EPSCs but decreased those mediated by NMDA receptors. EtOH (11-66 mM) also decreased current-evoked spike firing and this was accompanied by a decrease in input resistance and a modest hyperpolarization. EtOH inhibition of spike firing was prevented by the GABAA antagonist picrotoxin, but EtOH had no effect on evoked or spontaneous GABA IPSCs. EtOH increased the holding current of voltage-clamped neurons and this action was blocked by picrotoxin but not the more selective GABAA antagonist biccuculine. The glycine receptor antagonist strychnine also prevented EtOH's effect on holding current and spike firing, and western blotting revealed the presence of glycine receptors in lOFC. Overall, these results suggest that acutely, EtOH may reduce lOFC function via a glycine receptor dependent process and this may trigger neuroadaptive mechanisms that contribute to the impairment of OFC-dependent behaviors in alcohol-dependent subjects.
Author Beckley, Jacob T
Mulholland, Patrick J
Badanich, Kimberly A
Woodward, John J
Trantham-Davidson, Heather
Author_xml – sequence: 1
  givenname: Kimberly A
  surname: Badanich
  fullname: Badanich, Kimberly A
– sequence: 2
  givenname: Patrick J
  surname: Mulholland
  fullname: Mulholland, Patrick J
– sequence: 3
  givenname: Jacob T
  surname: Beckley
  fullname: Beckley, Jacob T
– sequence: 4
  givenname: Heather
  surname: Trantham-Davidson
  fullname: Trantham-Davidson, Heather
– sequence: 5
  givenname: John J
  surname: Woodward
  fullname: Woodward, John J
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27374567$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23314219$$D View this record in MEDLINE/PubMed
BookMark eNqNkttrFDEUh4NU7Lb65LsMiCDIrrnNZOZFkHWtwmpBVPoWzmTO2JTZZEwysvvfm223XooP5iXk5Du_cz0hR847JOQxowtGRf3SjeOCUyYWjN8jM6YknVdCXhyRGa0bMWdCXByTkxivKGWlquoH5JgLwSRnzYxsV-kSnB-KT9hNBmPxEafgHQzFamtsgtYONu0K3xdrSBiy_Ty0Nvk-Qym_lj4k3B68YvHVQgHF2bAz1mHWNDgmH4o3OKLr0KXiA5ocz8bNQ3K_hyHio8N9Sr68XX1evpuvz8_eL1-v50Yqnuat4qVoWygNSFkCFQ0qrnopFahKQs1oPmC4ZCDqjtHWILIOIRfIWt5JcUpe3eiOU7vBzuQkchV6DHYDYac9WP33j7OX-pv_oUVVVqKiWeD5QSD47xPGpDc2GhwGcOinqJkoq0Zwlnv9HyjnqhGVyujTO-iVn0Lu-zVFm6pWbC_45M_kf2V9O78MPDsAEA0MfQBnbPzNKaFkeR2O3XAm-BgD9no_3GT9vmY7aEb1fpd03iW93yXNePZ5ccfnVvZf9E8pDstM
CODEN NEROEW
CitedBy_id crossref_primary_10_1124_jpet_117_243840
crossref_primary_10_3389_fnmol_2018_00228
crossref_primary_10_1016_j_tips_2014_04_009
crossref_primary_10_3389_fnmol_2023_1098211
crossref_primary_10_1111_acer_14918
crossref_primary_10_1007_s11064_017_2462_y
crossref_primary_10_1016_j_alcohol_2020_06_001
crossref_primary_10_1038_s41380_023_02236_3
crossref_primary_10_1111_adb_12698
crossref_primary_10_1016_j_neuropharm_2021_108780
crossref_primary_10_1124_pr_113_007468
crossref_primary_10_1124_jpet_114_221895
crossref_primary_10_1111_adb_12726
crossref_primary_10_3389_fnins_2022_848648
crossref_primary_10_1093_cercor_bhw312
crossref_primary_10_3389_fncel_2016_00114
crossref_primary_10_3390_ijms19102992
crossref_primary_10_3390_ijms20184419
crossref_primary_10_1523_ENEURO_0052_21_2021
crossref_primary_10_1016_j_neuroscience_2024_01_019
crossref_primary_10_1016_j_neuropharm_2013_07_025
crossref_primary_10_1523_ENEURO_0402_19_2020
crossref_primary_10_1016_j_neuropharm_2023_109463
crossref_primary_10_1038_npp_2013_350
crossref_primary_10_1016_j_neuropharm_2025_110365
crossref_primary_10_1111_acer_14463
crossref_primary_10_1016_j_pnpbp_2018_01_010
crossref_primary_10_1016_j_neuropharm_2018_04_019
crossref_primary_10_1016_j_tips_2017_03_002
crossref_primary_10_3389_fphar_2018_01458
crossref_primary_10_1523_ENEURO_0077_20_2020
crossref_primary_10_1007_s10571_017_0571_4
crossref_primary_10_1016_j_neuropharm_2016_03_031
crossref_primary_10_1523_ENEURO_0503_20_2021
crossref_primary_10_1523_JNEUROSCI_0831_23_2023
crossref_primary_10_1038_npp_2015_250
crossref_primary_10_1152_jn_00714_2013
crossref_primary_10_3389_fncel_2016_00189
crossref_primary_10_1016_j_neuroscience_2015_03_034
crossref_primary_10_1111_adb_12635
crossref_primary_10_1111_acer_14697
crossref_primary_10_1016_j_neuron_2017_10_032
crossref_primary_10_26599_SAB_2022_9060018
crossref_primary_10_1038_s41380_021_01189_9
crossref_primary_10_1016_j_alcohol_2021_11_004
crossref_primary_10_1038_npp_2013_326
crossref_primary_10_1016_j_neuropharm_2017_04_007
crossref_primary_10_3389_fnsyn_2022_936911
crossref_primary_10_1016_j_alcohol_2014_07_017
crossref_primary_10_1016_j_neuropharm_2019_107688
crossref_primary_10_1007_s00213_016_4395_6
crossref_primary_10_1016_j_neuropharm_2021_108501
crossref_primary_10_1073_pnas_1703839114
crossref_primary_10_1016_j_neuropharm_2020_108007
crossref_primary_10_1038_npp_2017_22
crossref_primary_10_1016_j_neuropharm_2021_108750
crossref_primary_10_1371_journal_pone_0099208
crossref_primary_10_1371_journal_pone_0118721
crossref_primary_10_1111_acer_15210
Cites_doi 10.1038/sj.bjp.0703100
10.1111/j.1530-0277.1999.tb04122.x
10.1523/JNEUROSCI.5077-03.2004
10.1038/407
10.1097/01.ALC.0000131979.78003.34
10.1016/j.neubiorev.2004.09.006
10.1093/cercor/10.3.272
10.1016/S1388-2457(01)00691-5
10.1074/jbc.M504120200
10.1016/j.biopsych.2008.07.030
10.1523/JNEUROSCI.2551-07.2007
10.1186/1423-0127-17-S1-S1
10.1016/j.neuropharm.2008.07.034
10.1038/nn1813
10.1111/j.1530-0277.2006.00079.x
10.1080/10673220490910844
10.1046/j.0953-816x.2001.01730.x
10.1016/j.pharmthera.2005.11.002
10.1093/cercor/bhk009
10.1523/JNEUROSCI.18-01-00428.1998
10.1016/0013-4694(95)00239-1
10.1523/JNEUROSCI.10-04-01372.1990
10.1007/BF00235545
10.1523/JNEUROSCI.20-21-08199.2000
10.1111/j.1530-0277.2008.00625.x
10.1097/00001756-199312000-00029
10.1037/a0025922
10.1016/S0168-0102(01)00287-5
10.1002/cne.20349
10.1196/annals.1390.001
10.1016/j.ejphar.2009.04.034
10.1523/JNEUROSCI.23-09-03623.2003
10.1126/science.1171203
10.1046/j.1471-4159.1997.69062345.x
10.1111/j.1530-0277.1998.tb03712.x
10.1111/j.1471-4159.2007.04680.x
10.1038/19525
10.1038/sj.npp.1301449
10.1038/sj.npp.1301504
10.1523/JNEUROSCI.1184-06.2006
10.1111/j.1369-1600.2010.00206.x
10.1124/jpet.108.139303
10.1074/jbc.M110.134676
10.1074/jbc.M210167200
10.1016/j.biopsych.2008.09.001
10.1111/j.1749-6632.1995.tb38127.x
10.1152/jn.1995.74.2.733
10.1124/mol.110.068643
10.1523/JNEUROSCI.2820-08.2008
10.1074/jbc.M511022200
10.1046/j.1471-4159.1995.65010140.x
10.1016/j.brainres.2012.01.050
10.1523/JNEUROSCI.2040-04.2004
10.1523/JNEUROSCI.4749-06.2007
10.1073/pnas.0437926100
10.1523/JNEUROSCI.5378-06.2007
10.1016/j.neuroscience.2008.01.064
10.1016/0896-6273(93)90145-H
10.1073/pnas.1113820109
10.1016/j.brainres.2011.03.073
ContentType Journal Article
Copyright 2014 INIST-CNRS
Copyright Nature Publishing Group Jun 2013
Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology
Copyright_xml – notice: 2014 INIST-CNRS
– notice: Copyright Nature Publishing Group Jun 2013
– notice: Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1038/npp.2013.12
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Psychology
Neurosciences Abstracts

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate OFC neurons and ethanol
EISSN 1740-634X
EndPage 1188
ExternalDocumentID PMC3656360
2970115421
23314219
27374567
10_1038_npp_2013_12
Genre Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: NIAAA NIH HHS
  grantid: P50 AA010761
– fundername: NIAAA NIH HHS
  grantid: T32 AA007474
– fundername: NIAAA NIH HHS
  grantid: R37 AA009986
– fundername: NIAAA NIH HHS
  grantid: F32 AA019610
GroupedDBID ---
-DZ
-Q-
0R~
29N
2WC
36B
39C
4.4
406
5RE
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AANZL
AASML
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABFSG
ABIVO
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMFV
ACMJI
ACPRK
ACRQY
ACSTC
ACZOJ
ADBBV
ADFRT
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
ASPBG
ATHPR
AVWKF
AYFIA
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DIK
DNIVK
DPUIP
DWQXO
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FDB
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
GNUQQ
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JZLTJ
KQ8
M1P
M2M
M7P
MK0
NQJWS
O9-
OK1
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
UKHRP
W2D
ZGI
--K
1B1
53G
5VS
AACDK
AAEDT
AALRI
AAQFI
AAQXK
AATNV
AAXUO
ABMAC
ABRTQ
ABWVN
ACIUM
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEUPX
AFPUW
AGQPQ
AILAN
CAG
COF
FEDTE
FGOYB
FIGPU
HVGLF
IHE
IQODW
LGEZI
LOTEE
M41
NADUK
NQ-
NXXTH
PJZUB
PPXIY
PQGLB
R2-
RIG
RNS
RPZ
SEW
SSZ
ZKB
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7XB
8FE
8FH
8FK
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c472t-b7253bba5ca445a039e727f447a764a810000ac241a38d10bcee1dea3311b2d43
IEDL.DBID 7X7
ISSN 0893-133X
1740-634X
IngestDate Thu Aug 21 18:43:04 EDT 2025
Fri Jul 11 08:48:42 EDT 2025
Fri Jul 11 08:14:30 EDT 2025
Sat Aug 23 13:18:36 EDT 2025
Mon Jul 21 06:05:52 EDT 2025
Mon Jul 21 09:15:22 EDT 2025
Tue Jul 01 01:05:24 EDT 2025
Thu Apr 24 23:07:16 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords alcohol
Stimulant
Orbitofrontal cortex
Ethanol
Central nervous system
Electrophysiology
Excitability
Patch clamp method
Glycine
Encephalon
Alcoholic beverage
patch-clamp electrophysiology
Neuron
tonic current
Aminoacid
Glycine receptor
NMDA
GABA
Mechanism of action
Language English
License http://www.springer.com/tdm
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c472t-b7253bba5ca445a039e727f447a764a810000ac241a38d10bcee1dea3311b2d43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-News-3
content type line 23
OpenAccessLink https://www.nature.com/articles/npp201312.pdf
PMID 23314219
PQID 1350968719
PQPubID 33935
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3656360
proquest_miscellaneous_1356932189
proquest_miscellaneous_1352279367
proquest_journals_1350968719
pubmed_primary_23314219
pascalfrancis_primary_27374567
crossref_citationtrail_10_1038_npp_2013_12
crossref_primary_10_1038_npp_2013_12
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-06-01
PublicationDateYYYYMMDD 2013-06-01
PublicationDate_xml – month: 06
  year: 2013
  text: 2013-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Basingstoke
PublicationPlace_xml – name: Basingstoke
– name: England
– name: New York
PublicationTitle Neuropsychopharmacology (New York, N.Y.)
PublicationTitleAlternate Neuropsychopharmacology
PublicationYear 2013
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
References L Adermark (BFnpp201312_CR1) 2011; 16
HJ Otton (BFnpp201312_CR36) 2009; 614
JL Weiner (BFnpp201312_CR56) 2006; 111
M Roberto (BFnpp201312_CR38) 2003; 100
H Bokura (BFnpp201312_CR11) 2001; 112
GB Bissonette (BFnpp201312_CR8) 2008; 28
N Suvarna (BFnpp201312_CR46) 2005; 280
W Schultz (BFnpp201312_CR44) 2000; 10
G Schoenbaum (BFnpp201312_CR43) 1995; 74
JY Wu (BFnpp201312_CR59) 2010; 17
A Verdejo-Garcia (BFnpp201312_CR52) 2006; 12
T Kuner (BFnpp201312_CR26) 1993; 5
T Blevins (BFnpp201312_CR9) 1997; 69
SJ Thorpe (BFnpp201312_CR48) 1983; 49
SY Hill (BFnpp201312_CR19) 2009; 65
A Smith (BFnpp201312_CR45) 2004; 28
TA Wills (BFnpp201312_CR58) 2012; 109
F Jia (BFnpp201312_CR22) 2008; 326
HU Zeilhofer (BFnpp201312_CR63) 2005; 482
DS Wang (BFnpp201312_CR53) 2006; 281
PH Wu (BFnpp201312_CR60) 2011; 80
B Chu (BFnpp201312_CR12) 1995; 65
C Liston (BFnpp201312_CR27) 2006; 26
G Schoenbaum (BFnpp201312_CR42) 1998; 1
RM Alvestad (BFnpp201312_CR3) 2003; 278
Y Tu (BFnpp201312_CR50) 2007; 27
J Glykys (BFnpp201312_CR18) 2007; 10
E Dias-Ferreira (BFnpp201312_CR16) 2009; 325
DL Anders (BFnpp201312_CR4) 1999; 23
DK Crawford (BFnpp201312_CR13) 2007; 102
W Wei (BFnpp201312_CR55) 2004; 24
CA Boettiger (BFnpp201312_CR10) 2007; 27
S Ito (BFnpp201312_CR21) 2001; 41
C Jin (BFnpp201312_CR23) 2006; 30
Y Lu (BFnpp201312_CR30) 2011; 1393
JL Cummings (BFnpp201312_CR14) 1995; 769
KBJ Franklin (BFnpp201312_CR17) 2008
E Nunez (BFnpp201312_CR35) 2000; 129
SJ Ramus (BFnpp201312_CR37) 2000; 20
S Jonsson (BFnpp201312_CR24) 2012; 1446
KA Badanich (BFnpp201312_CR6) 2011; 125
A Ikeda (BFnpp201312_CR20) 1996; 98
J Wang (BFnpp201312_CR54) 2007; 27
LH Zhang (BFnpp201312_CR64) 2008; 33
CF Valenzuela (BFnpp201312_CR51) 1998; 22
GE Yevenes (BFnpp201312_CR62) 2010; 285
MP Mascia (BFnpp201312_CR32) 1996; 50
J Tanabe (BFnpp201312_CR47) 2009; 65
DM Lovinger (BFnpp201312_CR29) 1990; 10
MR Roesch (BFnpp201312_CR41) 2007; 17
R Yaka (BFnpp201312_CR61) 2003; 23
JW Lynch (BFnpp201312_CR31) 2009; 56
B Adinoff (BFnpp201312_CR2) 2004; 12
C Weitlauf (BFnpp201312_CR57) 2008; 32
BA McCool (BFnpp201312_CR33) 2001; 14
M Roberto (BFnpp201312_CR39) 2004; 24
JW Dalley (BFnpp201312_CR15) 2004; 28
L Tremblay (BFnpp201312_CR49) 1999; 398
DM Lovinger (BFnpp201312_CR28) 1995; 274
MR Roesch (BFnpp201312_CR40) 2007; 1104
TL Kash (BFnpp201312_CR25) 2008; 33
J McGaughy (BFnpp201312_CR34) 2008; 153
D Attwell (BFnpp201312_CR5) 1993; 11
A Bechara (BFnpp201312_CR7) 1998; 18
15611994 - J Comp Neurol. 2005 Feb 7;482(2):123-41
16903133 - J Int Neuropsychol Soc. 2006 May;12(3):405-15
10069568 - Alcohol Clin Exp Res. 1999 Feb;23(2):357-62
20647311 - J Biol Chem. 2010 Sep 24;285(39):30203-13
10683205 - Br J Pharmacol. 2000 Feb;129(4):802-10
10195132 - Nat Neurosci. 1998 Jun;1(2):155-9
18986649 - Biol Psychiatry. 2009 Jan 15;65(2):129-36
9726286 - Alcohol Clin Exp Res. 1998 Aug;22(5):1132-6
12566570 - Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2053-8
22330726 - Brain Res. 2012 Mar 29;1446:12-21
15252289 - Alcohol Clin Exp Res. 2004 Jul;28(7):1028-38
9375665 - J Neurochem. 1997 Dec;69(6):2345-54
9412519 - J Neurosci. 1998 Jan 1;18(1):428-37
7472378 - J Neurophysiol. 1995 Aug;74(2):733-50
20331561 - Addict Biol. 2011 Jan;16(1):43-54
22122149 - Behav Neurosci. 2011 Dec;125(6):879-91
7905294 - Neuroreport. 1993 Dec 13;5(3):297-300
22219357 - Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):E278-87
19644122 - Science. 2009 Jul 31;325(5940):621-5
8631280 - Electroencephalogr Clin Neurophysiol. 1996 Mar;98(3):206-12
18971455 - J Neurosci. 2008 Oct 29;28(44):11124-30
17460089 - J Neurosci. 2007 Apr 25;27(17):4765-75
10227292 - Nature. 1999 Apr 22;398(6729):704-8
18341645 - Alcohol Clin Exp Res. 2008 Apr;32(4):690-8
17159992 - Nat Neurosci. 2007 Jan;10(1):40-8
18355972 - Neuroscience. 2008 Apr 22;153(1):63-71
6861938 - Exp Brain Res. 1983;49(1):93-115
11672839 - Neurosci Res. 2001 Nov;41(3):257-66
8595019 - Ann N Y Acad Sci. 1995 Dec 15;769:1-13
7540660 - J Neurochem. 1995 Jul;65(1):140-8
12536146 - J Biol Chem. 2003 Mar 28;278(13):11020-5
16009711 - J Biol Chem. 2005 Sep 9;280(36):31450-9
16427127 - Pharmacol Ther. 2006 Sep;111(3):533-54
17625498 - Neuropsychopharmacology. 2008 May;33(6):1379-90
2158533 - J Neurosci. 1990 Apr;10(4):1372-9
17392475 - J Neurosci. 2007 Mar 28;27(13):3593-602
21680777 - Mol Pharmacol. 2011 Sep;80(3):529-37
17522628 - Neuropsychopharmacology. 2008 Feb;33(3):701-11
18801475 - Biol Psychiatry. 2009 Jan 15;65(2):160-4
14973247 - J Neurosci. 2004 Feb 18;24(7):1594-603
15764467 - Harv Rev Psychiatry. 2004 Nov-Dec;12(6):305-20
7616394 - J Pharmacol Exp Ther. 1995 Jul;274(1):164-72
16870732 - J Neurosci. 2006 Jul 26;26(30):7870-4
18160646 - J Neurosci. 2007 Dec 26;27(52):14383-91
16344549 - J Biol Chem. 2006 Feb 17;281(7):3841-55
18477766 - J Pharmacol Exp Ther. 2008 Aug;326(2):475-82
12736333 - J Neurosci. 2003 May 1;23(9):3623-32
16573586 - Alcohol Clin Exp Res. 2006 Apr;30(4):673-9
10731222 - Cereb Cortex. 2000 Mar;10(3):272-84
11738192 - Clin Neurophysiol. 2001 Dec;112(12):2224-32
15385620 - J Neurosci. 2004 Sep 22;24(38):8379-82
8700149 - Mol Pharmacol. 1996 Aug;50(2):402-6
17344533 - Ann N Y Acad Sci. 2007 May;1104:21-34
8104430 - Neuron. 1993 Sep;11(3):401-7
18721822 - Neuropharmacology. 2009 Jan;56(1):303-9
19394328 - Eur J Pharmacol. 2009 Jul 1;614(1-3):14-21
21524730 - Brain Res. 2011 Jun 1;1393:17-22
11050143 - J Neurosci. 2000 Nov 1;20(21):8199-208
20804583 - J Biomed Sci. 2010;17 Suppl 1:S1
16699083 - Cereb Cortex. 2007 Mar;17(3):643-52
15555683 - Neurosci Biobehav Rev. 2004 Nov;28(7):771-84
11683900 - Eur J Neurosci. 2001 Oct;14(7):1082-90
17561937 - J Neurochem. 2007 Sep;102(6):2097-109
References_xml – volume: 129
  start-page: 802
  year: 2000
  ident: BFnpp201312_CR35
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0703100
– volume: 23
  start-page: 357
  year: 1999
  ident: BFnpp201312_CR4
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.1999.tb04122.x
– volume: 24
  start-page: 1594
  year: 2004
  ident: BFnpp201312_CR39
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5077-03.2004
– volume: 1
  start-page: 155
  year: 1998
  ident: BFnpp201312_CR42
  publication-title: Nat Neurosci
  doi: 10.1038/407
– volume: 28
  start-page: 1028
  year: 2004
  ident: BFnpp201312_CR45
  publication-title: Alcohol Clin Exp Res
  doi: 10.1097/01.ALC.0000131979.78003.34
– volume: 28
  start-page: 771
  year: 2004
  ident: BFnpp201312_CR15
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2004.09.006
– volume: 10
  start-page: 272
  year: 2000
  ident: BFnpp201312_CR44
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/10.3.272
– volume: 112
  start-page: 2224
  year: 2001
  ident: BFnpp201312_CR11
  publication-title: Clin Neurophysiol
  doi: 10.1016/S1388-2457(01)00691-5
– volume: 280
  start-page: 31450
  year: 2005
  ident: BFnpp201312_CR46
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M504120200
– volume: 65
  start-page: 160
  year: 2009
  ident: BFnpp201312_CR47
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2008.07.030
– volume: 27
  start-page: 14383
  year: 2007
  ident: BFnpp201312_CR10
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2551-07.2007
– volume: 17
  start-page: S1
  issue: Suppl 1
  year: 2010
  ident: BFnpp201312_CR59
  publication-title: J Biomed Sci
  doi: 10.1186/1423-0127-17-S1-S1
– volume: 12
  start-page: 405
  year: 2006
  ident: BFnpp201312_CR52
  publication-title: J Int Neuropsychol Soc
– volume: 56
  start-page: 303
  year: 2009
  ident: BFnpp201312_CR31
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2008.07.034
– volume: 10
  start-page: 40
  year: 2007
  ident: BFnpp201312_CR18
  publication-title: Nat Neurosci
  doi: 10.1038/nn1813
– volume: 30
  start-page: 673
  year: 2006
  ident: BFnpp201312_CR23
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.2006.00079.x
– volume: 12
  start-page: 305
  year: 2004
  ident: BFnpp201312_CR2
  publication-title: Harv Rev Psychiatry
  doi: 10.1080/10673220490910844
– volume: 14
  start-page: 1082
  year: 2001
  ident: BFnpp201312_CR33
  publication-title: Eur J Neurosci
  doi: 10.1046/j.0953-816x.2001.01730.x
– volume: 111
  start-page: 533
  year: 2006
  ident: BFnpp201312_CR56
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2005.11.002
– volume: 17
  start-page: 643
  year: 2007
  ident: BFnpp201312_CR41
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/bhk009
– volume-title: The mouse brain in stereotaxic coordinates
  year: 2008
  ident: BFnpp201312_CR17
– volume: 18
  start-page: 428
  year: 1998
  ident: BFnpp201312_CR7
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.18-01-00428.1998
– volume: 98
  start-page: 206
  year: 1996
  ident: BFnpp201312_CR20
  publication-title: Electroencephalogr Clin Neurophysiol
  doi: 10.1016/0013-4694(95)00239-1
– volume: 10
  start-page: 1372
  year: 1990
  ident: BFnpp201312_CR29
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.10-04-01372.1990
– volume: 49
  start-page: 93
  year: 1983
  ident: BFnpp201312_CR48
  publication-title: Exp Brain Res
  doi: 10.1007/BF00235545
– volume: 50
  start-page: 402
  year: 1996
  ident: BFnpp201312_CR32
  publication-title: Mol Pharmacol
– volume: 20
  start-page: 8199
  year: 2000
  ident: BFnpp201312_CR37
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.20-21-08199.2000
– volume: 32
  start-page: 690
  year: 2008
  ident: BFnpp201312_CR57
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.2008.00625.x
– volume: 5
  start-page: 297
  year: 1993
  ident: BFnpp201312_CR26
  publication-title: Neuroreport
  doi: 10.1097/00001756-199312000-00029
– volume: 125
  start-page: 879
  year: 2011
  ident: BFnpp201312_CR6
  publication-title: Behav Neurosci
  doi: 10.1037/a0025922
– volume: 41
  start-page: 257
  year: 2001
  ident: BFnpp201312_CR21
  publication-title: Neurosci Res
  doi: 10.1016/S0168-0102(01)00287-5
– volume: 482
  start-page: 123
  year: 2005
  ident: BFnpp201312_CR63
  publication-title: J Comp Neurol
  doi: 10.1002/cne.20349
– volume: 1104
  start-page: 21
  year: 2007
  ident: BFnpp201312_CR40
  publication-title: Ann N Y Acad Sci
  doi: 10.1196/annals.1390.001
– volume: 614
  start-page: 14
  year: 2009
  ident: BFnpp201312_CR36
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2009.04.034
– volume: 274
  start-page: 164
  year: 1995
  ident: BFnpp201312_CR28
  publication-title: J Pharmacol Exp Ther
– volume: 23
  start-page: 3623
  year: 2003
  ident: BFnpp201312_CR61
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-09-03623.2003
– volume: 325
  start-page: 621
  year: 2009
  ident: BFnpp201312_CR16
  publication-title: Science
  doi: 10.1126/science.1171203
– volume: 69
  start-page: 2345
  year: 1997
  ident: BFnpp201312_CR9
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1997.69062345.x
– volume: 22
  start-page: 1132
  year: 1998
  ident: BFnpp201312_CR51
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.1998.tb03712.x
– volume: 102
  start-page: 2097
  year: 2007
  ident: BFnpp201312_CR13
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2007.04680.x
– volume: 398
  start-page: 704
  year: 1999
  ident: BFnpp201312_CR49
  publication-title: Nature
  doi: 10.1038/19525
– volume: 33
  start-page: 701
  year: 2008
  ident: BFnpp201312_CR64
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301449
– volume: 33
  start-page: 1379
  year: 2008
  ident: BFnpp201312_CR25
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301504
– volume: 26
  start-page: 7870
  year: 2006
  ident: BFnpp201312_CR27
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1184-06.2006
– volume: 16
  start-page: 43
  year: 2011
  ident: BFnpp201312_CR1
  publication-title: Addict Biol
  doi: 10.1111/j.1369-1600.2010.00206.x
– volume: 326
  start-page: 475
  year: 2008
  ident: BFnpp201312_CR22
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.108.139303
– volume: 285
  start-page: 30203
  year: 2010
  ident: BFnpp201312_CR62
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.134676
– volume: 278
  start-page: 11020
  year: 2003
  ident: BFnpp201312_CR3
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M210167200
– volume: 65
  start-page: 129
  year: 2009
  ident: BFnpp201312_CR19
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2008.09.001
– volume: 769
  start-page: 1
  year: 1995
  ident: BFnpp201312_CR14
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.1995.tb38127.x
– volume: 74
  start-page: 733
  year: 1995
  ident: BFnpp201312_CR43
  publication-title: J Neurophysiol
  doi: 10.1152/jn.1995.74.2.733
– volume: 80
  start-page: 529
  year: 2011
  ident: BFnpp201312_CR60
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.110.068643
– volume: 28
  start-page: 11124
  year: 2008
  ident: BFnpp201312_CR8
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2820-08.2008
– volume: 281
  start-page: 3841
  year: 2006
  ident: BFnpp201312_CR53
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M511022200
– volume: 65
  start-page: 140
  year: 1995
  ident: BFnpp201312_CR12
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1995.65010140.x
– volume: 1446
  start-page: 12
  year: 2012
  ident: BFnpp201312_CR24
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2012.01.050
– volume: 24
  start-page: 8379
  year: 2004
  ident: BFnpp201312_CR55
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2040-04.2004
– volume: 27
  start-page: 3593
  year: 2007
  ident: BFnpp201312_CR54
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4749-06.2007
– volume: 100
  start-page: 2053
  year: 2003
  ident: BFnpp201312_CR38
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0437926100
– volume: 27
  start-page: 4765
  year: 2007
  ident: BFnpp201312_CR50
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5378-06.2007
– volume: 153
  start-page: 63
  year: 2008
  ident: BFnpp201312_CR34
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2008.01.064
– volume: 11
  start-page: 401
  year: 1993
  ident: BFnpp201312_CR5
  publication-title: Neuron
  doi: 10.1016/0896-6273(93)90145-H
– volume: 109
  start-page: E278
  year: 2012
  ident: BFnpp201312_CR58
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1113820109
– volume: 1393
  start-page: 17
  year: 2011
  ident: BFnpp201312_CR30
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2011.03.073
– reference: 9375665 - J Neurochem. 1997 Dec;69(6):2345-54
– reference: 16344549 - J Biol Chem. 2006 Feb 17;281(7):3841-55
– reference: 18801475 - Biol Psychiatry. 2009 Jan 15;65(2):160-4
– reference: 17561937 - J Neurochem. 2007 Sep;102(6):2097-109
– reference: 10227292 - Nature. 1999 Apr 22;398(6729):704-8
– reference: 11672839 - Neurosci Res. 2001 Nov;41(3):257-66
– reference: 18341645 - Alcohol Clin Exp Res. 2008 Apr;32(4):690-8
– reference: 10195132 - Nat Neurosci. 1998 Jun;1(2):155-9
– reference: 17522628 - Neuropsychopharmacology. 2008 Feb;33(3):701-11
– reference: 19394328 - Eur J Pharmacol. 2009 Jul 1;614(1-3):14-21
– reference: 2158533 - J Neurosci. 1990 Apr;10(4):1372-9
– reference: 18477766 - J Pharmacol Exp Ther. 2008 Aug;326(2):475-82
– reference: 20647311 - J Biol Chem. 2010 Sep 24;285(39):30203-13
– reference: 8104430 - Neuron. 1993 Sep;11(3):401-7
– reference: 10731222 - Cereb Cortex. 2000 Mar;10(3):272-84
– reference: 14973247 - J Neurosci. 2004 Feb 18;24(7):1594-603
– reference: 8631280 - Electroencephalogr Clin Neurophysiol. 1996 Mar;98(3):206-12
– reference: 8700149 - Mol Pharmacol. 1996 Aug;50(2):402-6
– reference: 16009711 - J Biol Chem. 2005 Sep 9;280(36):31450-9
– reference: 6861938 - Exp Brain Res. 1983;49(1):93-115
– reference: 10683205 - Br J Pharmacol. 2000 Feb;129(4):802-10
– reference: 16573586 - Alcohol Clin Exp Res. 2006 Apr;30(4):673-9
– reference: 18986649 - Biol Psychiatry. 2009 Jan 15;65(2):129-36
– reference: 18971455 - J Neurosci. 2008 Oct 29;28(44):11124-30
– reference: 17392475 - J Neurosci. 2007 Mar 28;27(13):3593-602
– reference: 16870732 - J Neurosci. 2006 Jul 26;26(30):7870-4
– reference: 20331561 - Addict Biol. 2011 Jan;16(1):43-54
– reference: 12566570 - Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2053-8
– reference: 15555683 - Neurosci Biobehav Rev. 2004 Nov;28(7):771-84
– reference: 7616394 - J Pharmacol Exp Ther. 1995 Jul;274(1):164-72
– reference: 15611994 - J Comp Neurol. 2005 Feb 7;482(2):123-41
– reference: 15764467 - Harv Rev Psychiatry. 2004 Nov-Dec;12(6):305-20
– reference: 12736333 - J Neurosci. 2003 May 1;23(9):3623-32
– reference: 7472378 - J Neurophysiol. 1995 Aug;74(2):733-50
– reference: 9412519 - J Neurosci. 1998 Jan 1;18(1):428-37
– reference: 18160646 - J Neurosci. 2007 Dec 26;27(52):14383-91
– reference: 22219357 - Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):E278-87
– reference: 7905294 - Neuroreport. 1993 Dec 13;5(3):297-300
– reference: 10069568 - Alcohol Clin Exp Res. 1999 Feb;23(2):357-62
– reference: 7540660 - J Neurochem. 1995 Jul;65(1):140-8
– reference: 20804583 - J Biomed Sci. 2010;17 Suppl 1:S1
– reference: 11683900 - Eur J Neurosci. 2001 Oct;14(7):1082-90
– reference: 17625498 - Neuropsychopharmacology. 2008 May;33(6):1379-90
– reference: 11738192 - Clin Neurophysiol. 2001 Dec;112(12):2224-32
– reference: 12536146 - J Biol Chem. 2003 Mar 28;278(13):11020-5
– reference: 18355972 - Neuroscience. 2008 Apr 22;153(1):63-71
– reference: 16427127 - Pharmacol Ther. 2006 Sep;111(3):533-54
– reference: 9726286 - Alcohol Clin Exp Res. 1998 Aug;22(5):1132-6
– reference: 15252289 - Alcohol Clin Exp Res. 2004 Jul;28(7):1028-38
– reference: 8595019 - Ann N Y Acad Sci. 1995 Dec 15;769:1-13
– reference: 11050143 - J Neurosci. 2000 Nov 1;20(21):8199-208
– reference: 17344533 - Ann N Y Acad Sci. 2007 May;1104:21-34
– reference: 19644122 - Science. 2009 Jul 31;325(5940):621-5
– reference: 16903133 - J Int Neuropsychol Soc. 2006 May;12(3):405-15
– reference: 15385620 - J Neurosci. 2004 Sep 22;24(38):8379-82
– reference: 21680777 - Mol Pharmacol. 2011 Sep;80(3):529-37
– reference: 22122149 - Behav Neurosci. 2011 Dec;125(6):879-91
– reference: 18721822 - Neuropharmacology. 2009 Jan;56(1):303-9
– reference: 21524730 - Brain Res. 2011 Jun 1;1393:17-22
– reference: 22330726 - Brain Res. 2012 Mar 29;1446:12-21
– reference: 16699083 - Cereb Cortex. 2007 Mar;17(3):643-52
– reference: 17159992 - Nat Neurosci. 2007 Jan;10(1):40-8
– reference: 17460089 - J Neurosci. 2007 Apr 25;27(17):4765-75
SSID ssj0015768
Score 2.3519042
Snippet Trauma-induced damage to the orbitofrontal cortex (OFC) often results in behavioral inflexibility and impaired judgment. Human alcoholics exhibit similar...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1176
SubjectTerms Action Potentials - drug effects
Action Potentials - physiology
Alcoholism
Animals
Behavior
Bicuculline - pharmacology
Biological and medical sciences
Dose-Response Relationship, Drug
Drug Interactions
Ethanol
Ethanol - antagonists & inhibitors
Ethanol - pharmacology
Excitatory Postsynaptic Potentials - drug effects
Excitatory Postsynaptic Potentials - physiology
Flexibility
GABA Antagonists - pharmacology
Glycine Agents - pharmacology
In Vitro Techniques
Laboratory animals
Male
Medical sciences
Mice
Neurons
Neurons - drug effects
Neurons - physiology
Neurosciences
Original
Picrotoxin - pharmacology
Prefrontal Cortex - cytology
Prefrontal Cortex - drug effects
Prefrontal Cortex - physiology
Receptors, AMPA - drug effects
Receptors, Glycine - metabolism
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
Strychnine - pharmacology
Title Ethanol Reduces Neuronal Excitability of Lateral Orbitofrontal Cortex Neurons Via a Glycine Receptor Dependent Mechanism
URI https://www.ncbi.nlm.nih.gov/pubmed/23314219
https://www.proquest.com/docview/1350968719
https://www.proquest.com/docview/1352279367
https://www.proquest.com/docview/1356932189
https://pubmed.ncbi.nlm.nih.gov/PMC3656360
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9swEBZbC2NQxpZuXbYuaFD6MOrV-hHLfhpdl66MpSulHXkzsi2zQGqnsQvxf787WXGWUfpo-ywL30n6pLv7jpCDKNecCcM8rrTvSWV8L9I69wKRAP7IJE845juPL4LzG_ljMpy4A7fKhVWu5kQ7UWdlimfkx0wgUQnA--jL_M7DqlHoXXUlNJ6SbaQuQ6tWk27DxRBLWxQZCQ_2YhOXn-eL8LiYI1klE58Z31iRdua6gp-Tt1UtHoKd_0dP_rMcnb0kLxyOpCet4l-RJ6bokd2TAvbQtw09pDay0x6Z98izsXOg98jhZUtV3RzR63XmVXVk3-hIrJtdshzhmXo5o1fI7Woqalk88JOjZTqtW3bvhpY5_akxiXlGfy0SmB1yJESAq1MM4l26tyr6e6qppt9nDXYD2sRgmnJBv7kSvDUdG0xBnla3r8nN2ej69NxzVRq8VCpee4niQ5EkephqKYfaF5EBTJRLqbQKpA6tA0GngBS0CDPmJ7Ass8xoIRgDQ5DiDdkqysK8JdTP4Y6KMpVqTHUHdJgadBP6WaZzZXSffFppKk4dhTlW0pjF1pUuwhjUGqNaY8b75KATnrfMHQ-LDTZU3skCrlOALlWf7K9sIHbju4rX1tgnH7vHMDLR3aILU95bGaRnFNjEIzIBIGgWQjt7rVmtOwB_SHL8gtowuE4AmcE3nxTTP5YhXABKF4H_7vGuvyfPeVvcw_PZPtmqF_fmA0CsOhnYcTQg219HF5dXfwE3jSpZ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkGASQtABK4xhpLEHtLD4o3XzgNC0dXSsHQh1U9-CkziiUpeUphPNP8XfyJ3zUYqmve2xzcWxchff7-y73xGy68WaM2GYw5V2HamM63hax05bBIA_IskDjvXOg_N270J-GbVGa-RPVQuDaZXVmmgX6igNcY_8gAkkKgF4732a_nKwaxSerlYtNAqzODP5bwjZso-nx6Dfd5yfdIdHPafsKuCEUvG5EyjeEkGgW6GWsqVd4Rnw4bGUSqu21B274a1D8GxadCLmBuBGWGS0EIzBxKWAce-R--B4XQz21KgO8Bhid4taPeFA7Dcq6wFd0TlIpkiOycQHxlc84KOpzkAZcdFF4yaY-3-25j_u7-QJeVziVnpYGNpTsmaSBtk8TCBmv8rpHrWZpHaLvkEeDMoD-wbZ-1ZQY-f7dLis9Mr27R01aXa-SRZd3MNPJ_Q7csmajFrWEHxkdxGO5wWbeE7TmPY1Fk1P6NdZAKtRjAQM8OsIk4YX5V0ZvRxrqunnSY7TgDExeSed0eOy5e-cDgyWPI-zq2fk4k7095ysJ2litgh1Y_hHeZEKNZbWAxoNDR5LulGkY2V0k7yvNOWHJWU6du6Y-PboXnR8UKuPavUZb5LdWnhaMIXcLLazovJaFnCkAjSrmmS7sgG_XE8yf2n9TfK2vgwrAR7v6MSk11YG6SAFDnGLTBsQO-vAOC8Ks1pOAN6Q5PgEtWJwtQAyka9eScY_LSO5gKhAtN2Xt0_9DXnYGw76fv_0_OwV2eBFYxHHZdtkfT67Nq8B3s2DHftNUfLjrj_iv_xTZOw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVKqQEIKUR6CURSo9oJp4H8naB4RKk9DSJkRVW-Vm1vZaRErtEKci_mv8OmZsxyGo6q1H2-P1JrOPb3ZmviFkz400Z8IwiyttW1IZ23K1jqy28AF_hJL7HPOd-4P28aX8NmqNNsifZS4MhlUu18R8oQ6TAM_Im0wgUQnAe7cZlWERw07v8_SXhRWk0NO6LKdRDJFTk_0G8y39dNIBXb_nvNe9ODq2ygoDViAVn1u-4i3h-7oVaClb2haugf08klJp1ZbayQ-_dQC7nBZOyGwfthQWGi0EY_AjpIB2H5BNhVZRjWx-6Q6G55UPA5F8jmFdYYElOCqzA23hNOMpUmUy8ZHxtf3w0VSnoJqoqKlxG-j9P3bzn82w94Q8LlEsPSyG3VOyYeI62T6MwYK_zug-zeNK8wP7Otnql-77OtkfFkTZ2QG9WOV9pQf5GxWFdrZNFl080U8m9ByZZU1Kcw4R_GR3EYznBbd4RpOInmlMoZ7Q7zMf1qYI6Rjg6ghDiBflWym9Gmuq6ddJht2ANjGUJ5nRTlkAeE77BhOgx-n1M3J5Lxp8TmpxEpuXhNoR3FFuqAKNifaATQODTko7DHWkjG6QD0tNeUFJoI51PCZe7sgXjgdq9VCtHuMNslcJTwvekNvFdtdUXskCqlSAbVWD7CzHgFeuLqm3mgsN8q56DOsCOnt0bJKbXAbJIQU2cYdMG_A7c6CdF8WwWnUA_iHJ8QtqbcBVAshLvv4kHv_M-ckF2Aiibb-6u-tvyRZMYO_sZHD6mjzkRZURy2Y7pDaf3Zg3gPXm_m45qSj5cd_z-C-PAGqH
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ethanol+Reduces+Neuronal+Excitability+of+Lateral+Orbitofrontal+Cortex+Neurons+Via+a+Glycine+Receptor+Dependent+Mechanism&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Badanich%2C+Kimberly+A&rft.au=Mulholland%2C+Patrick+J&rft.au=Beckley%2C+Jacob+T&rft.au=Trantham-Davidson%2C+Heather&rft.date=2013-06-01&rft.issn=0893-133X&rft.eissn=1740-634X&rft.volume=38&rft.issue=7&rft.spage=1176&rft.epage=1188&rft_id=info:doi/10.1038%2Fnpp.2013.12&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_npp_2013_12
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon